{"id":5727,"date":"2025-01-28T14:41:13","date_gmt":"2025-01-28T13:41:13","guid":{"rendered":"https:\/\/crcm-marseille.fr\/uncategorized\/de-sepulveda-team-reveals-kinase-inactivity-of-man2a1-fer-oncoprotein-tyrosine-kinase-inhibitors-called-into-question\/"},"modified":"2025-04-23T16:30:40","modified_gmt":"2025-04-23T14:30:40","slug":"de-sepulveda-team-reveals-kinase-inactivity-of-man2a1-fer-oncoprotein-tyrosine-kinase-inhibitors-called-into-question","status":"publish","type":"post","link":"https:\/\/crcm-marseille.fr\/en\/scientific-publication\/de-sepulveda-team-reveals-kinase-inactivity-of-man2a1-fer-oncoprotein-tyrosine-kinase-inhibitors-called-into-question\/","title":{"rendered":"De Sepulveda team reveals kinase inactivity of MAN2A1-FER oncoprotein: tyrosine kinase inhibitors called into question"},"content":{"rendered":"\n<p>In this work, we demonstrate that a recurrent oncoprotein in cancers of the liver, lung, esophagus and other tumors lacks catalytic activity. The MAN2a1-FER fusion gene that includes the catalytic domain of the FER tyrosine kinase lacks some of the invariant amino acids in this type of enzyme, and we demonstrate that the effects attributed to the FER kinase moiety are recovered if a form of FER carrying an inactivating point mutation is expressed. Our results indicate that this oncoprotein cannot therefore be targeted with tyrosine kinase inhibitors, contrary to previous publications.<br\/><\/p>\n\n<p>Desaunay M, Voisset E, Letard S, Roche P, De Sepulveda P. <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38141924\/\">The Recurrent Liver MAN2A1-FER Oncoprotein Lacks Kinase Activity: Implications for the Use of Tyrosine Kinase Inhibitors.<\/a> Cell Mol Gastroenterol Hepatol. 2024;17(4):667-669.<\/p>\n\n<div style=\"height:50px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n<div class=\"wp-block-buttons is-content-justification-center is-layout-flex wp-container-core-buttons-is-layout-16018d1d wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button\"><a class=\"wp-block-button__link wp-element-button\" href=\"https:\/\/crcm-marseille.fr\/departement-ohio\/equipe-signalisation-hematopoiese-mecanismes-oncogenese-departement-ohio\/\">Find out more about the De Sepulveda team<\/a><\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Published in <i>Cellular and Molecular Gastroenterology and Hepatology<\/i>, the De Sepulveda team&#8217;s study demonstrates that the MAN2A1-FER oncoprotein, present in several cancers, lacks kinase activity, calling into question the efficacy of tyrosine kinase inhibitors as a therapeutic strategy.<\/p>\n","protected":false},"author":3,"featured_media":5471,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_tec_requires_first_save":true,"_EventAllDay":false,"_EventTimezone":"","_EventStartDate":"","_EventEndDate":"","_EventStartDateUTC":"","_EventEndDateUTC":"","_EventShowMap":false,"_EventShowMapLink":false,"_EventURL":"","_EventCost":"","_EventCostDescription":"","_EventCurrencySymbol":"","_EventCurrencyCode":"","_EventCurrencyPosition":"","_EventDateTimeSeparator":"","_EventTimeRangeSeparator":"","_EventOrganizerID":[],"_EventVenueID":[],"_OrganizerEmail":"","_OrganizerPhone":"","_OrganizerWebsite":"","_VenueAddress":"","_VenueCity":"","_VenueCountry":"","_VenueProvince":"","_VenueState":"","_VenueZip":"","_VenuePhone":"","_VenueURL":"","_VenueStateProvince":"","_VenueLat":"","_VenueLng":"","_VenueShowMap":false,"_VenueShowMapLink":false,"_tribe_blocks_recurrence_rules":"","_tribe_blocks_recurrence_description":"","_tribe_blocks_recurrence_exclusions":"","footnotes":""},"categories":[198,203,208],"tags":[],"class_list":["post-5727","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ohio-department","category-scientific-publication","category-sepulvedas-team"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>De Sepulveda team reveals kinase inactivity of MAN2A1-FER oncoprotein: tyrosine kinase inhibitors called into question | CRCM<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/crcm-marseille.fr\/en\/scientific-publication\/de-sepulveda-team-reveals-kinase-inactivity-of-man2a1-fer-oncoprotein-tyrosine-kinase-inhibitors-called-into-question\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"De Sepulveda team reveals kinase inactivity of MAN2A1-FER oncoprotein: tyrosine kinase inhibitors called into question | CRCM\" \/>\n<meta property=\"og:description\" content=\"Published in Cellular and Molecular Gastroenterology and Hepatology, the De Sepulveda team&#039;s study demonstrates that the MAN2A1-FER oncoprotein, present in several cancers, lacks kinase activity, calling into question the efficacy of tyrosine kinase inhibitors as a therapeutic strategy.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/crcm-marseille.fr\/en\/scientific-publication\/de-sepulveda-team-reveals-kinase-inactivity-of-man2a1-fer-oncoprotein-tyrosine-kinase-inhibitors-called-into-question\/\" \/>\n<meta property=\"og:site_name\" content=\"CRCM\" \/>\n<meta property=\"article:published_time\" content=\"2025-01-28T13:41:13+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-04-23T14:30:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/crcm-marseille.fr\/wp-content\/uploads\/2025\/01\/Sepulveda-News-2.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"760\" \/>\n\t<meta property=\"og:image:height\" content=\"453\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"L\u00e9a Girard\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"L\u00e9a Girard\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/crcm-marseille.fr\/en\/scientific-publication\/de-sepulveda-team-reveals-kinase-inactivity-of-man2a1-fer-oncoprotein-tyrosine-kinase-inhibitors-called-into-question\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/crcm-marseille.fr\/en\/scientific-publication\/de-sepulveda-team-reveals-kinase-inactivity-of-man2a1-fer-oncoprotein-tyrosine-kinase-inhibitors-called-into-question\/\"},\"author\":{\"name\":\"L\u00e9a Girard\",\"@id\":\"https:\/\/crcm-marseille.fr\/en\/#\/schema\/person\/62f07336c4eae6ba5829ec04ad81b1e3\"},\"headline\":\"De Sepulveda team reveals kinase inactivity of MAN2A1-FER oncoprotein: tyrosine kinase inhibitors called into question\",\"datePublished\":\"2025-01-28T13:41:13+00:00\",\"dateModified\":\"2025-04-23T14:30:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/crcm-marseille.fr\/en\/scientific-publication\/de-sepulveda-team-reveals-kinase-inactivity-of-man2a1-fer-oncoprotein-tyrosine-kinase-inhibitors-called-into-question\/\"},\"wordCount\":153,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/crcm-marseille.fr\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/crcm-marseille.fr\/en\/scientific-publication\/de-sepulveda-team-reveals-kinase-inactivity-of-man2a1-fer-oncoprotein-tyrosine-kinase-inhibitors-called-into-question\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/crcm-marseille.fr\/wp-content\/uploads\/2025\/01\/Sepulveda-News-2.jpg\",\"articleSection\":[\"OHIO Department\",\"Scientific publication\",\"Sepulveda team\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/crcm-marseille.fr\/en\/scientific-publication\/de-sepulveda-team-reveals-kinase-inactivity-of-man2a1-fer-oncoprotein-tyrosine-kinase-inhibitors-called-into-question\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/crcm-marseille.fr\/en\/scientific-publication\/de-sepulveda-team-reveals-kinase-inactivity-of-man2a1-fer-oncoprotein-tyrosine-kinase-inhibitors-called-into-question\/\",\"url\":\"https:\/\/crcm-marseille.fr\/en\/scientific-publication\/de-sepulveda-team-reveals-kinase-inactivity-of-man2a1-fer-oncoprotein-tyrosine-kinase-inhibitors-called-into-question\/\",\"name\":\"De Sepulveda team reveals kinase inactivity of MAN2A1-FER oncoprotein: tyrosine kinase inhibitors called into question | CRCM\",\"isPartOf\":{\"@id\":\"https:\/\/crcm-marseille.fr\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/crcm-marseille.fr\/en\/scientific-publication\/de-sepulveda-team-reveals-kinase-inactivity-of-man2a1-fer-oncoprotein-tyrosine-kinase-inhibitors-called-into-question\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/crcm-marseille.fr\/en\/scientific-publication\/de-sepulveda-team-reveals-kinase-inactivity-of-man2a1-fer-oncoprotein-tyrosine-kinase-inhibitors-called-into-question\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/crcm-marseille.fr\/wp-content\/uploads\/2025\/01\/Sepulveda-News-2.jpg\",\"datePublished\":\"2025-01-28T13:41:13+00:00\",\"dateModified\":\"2025-04-23T14:30:40+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/crcm-marseille.fr\/en\/scientific-publication\/de-sepulveda-team-reveals-kinase-inactivity-of-man2a1-fer-oncoprotein-tyrosine-kinase-inhibitors-called-into-question\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/crcm-marseille.fr\/en\/scientific-publication\/de-sepulveda-team-reveals-kinase-inactivity-of-man2a1-fer-oncoprotein-tyrosine-kinase-inhibitors-called-into-question\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/crcm-marseille.fr\/en\/scientific-publication\/de-sepulveda-team-reveals-kinase-inactivity-of-man2a1-fer-oncoprotein-tyrosine-kinase-inhibitors-called-into-question\/#primaryimage\",\"url\":\"https:\/\/crcm-marseille.fr\/wp-content\/uploads\/2025\/01\/Sepulveda-News-2.jpg\",\"contentUrl\":\"https:\/\/crcm-marseille.fr\/wp-content\/uploads\/2025\/01\/Sepulveda-News-2.jpg\",\"width\":760,\"height\":453},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/crcm-marseille.fr\/en\/scientific-publication\/de-sepulveda-team-reveals-kinase-inactivity-of-man2a1-fer-oncoprotein-tyrosine-kinase-inhibitors-called-into-question\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/crcm-marseille.fr\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"De Sepulveda team reveals kinase inactivity of MAN2A1-FER oncoprotein: tyrosine kinase inhibitors called into question\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/crcm-marseille.fr\/en\/#website\",\"url\":\"https:\/\/crcm-marseille.fr\/en\/\",\"name\":\"CRCM\",\"description\":\"Marseille Cancer Research Center\",\"publisher\":{\"@id\":\"https:\/\/crcm-marseille.fr\/en\/#organization\"},\"alternateName\":\"Centre de recherche en canc\u00e9rologie de Marseille\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/crcm-marseille.fr\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/crcm-marseille.fr\/en\/#organization\",\"name\":\"CRCM\",\"alternateName\":\"Centre de Recherche en Canc\u00e9rologie de Marseille\",\"url\":\"https:\/\/crcm-marseille.fr\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/crcm-marseille.fr\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/crcm-marseille.fr\/wp-content\/uploads\/2024\/10\/logo-crcm.png\",\"contentUrl\":\"https:\/\/crcm-marseille.fr\/wp-content\/uploads\/2024\/10\/logo-crcm.png\",\"width\":11811,\"height\":7171,\"caption\":\"CRCM\"},\"image\":{\"@id\":\"https:\/\/crcm-marseille.fr\/en\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.youtube.com\/@CRCM-marseille\",\"https:\/\/www.linkedin.com\/company\/crcm-marseille\/\",\"https:\/\/bsky.app\/profile\/crcm.bsky.social\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/crcm-marseille.fr\/en\/#\/schema\/person\/62f07336c4eae6ba5829ec04ad81b1e3\",\"name\":\"L\u00e9a Girard\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/crcm-marseille.fr\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/88ca43e6c11426af328e079c9e0e2998cafa03182fedc1404c00f26df9087825?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/88ca43e6c11426af328e079c9e0e2998cafa03182fedc1404c00f26df9087825?s=96&d=mm&r=g\",\"caption\":\"L\u00e9a Girard\"},\"url\":\"https:\/\/crcm-marseille.fr\/en\/author\/lea-girard\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"De Sepulveda team reveals kinase inactivity of MAN2A1-FER oncoprotein: tyrosine kinase inhibitors called into question | CRCM","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/crcm-marseille.fr\/en\/scientific-publication\/de-sepulveda-team-reveals-kinase-inactivity-of-man2a1-fer-oncoprotein-tyrosine-kinase-inhibitors-called-into-question\/","og_locale":"en_US","og_type":"article","og_title":"De Sepulveda team reveals kinase inactivity of MAN2A1-FER oncoprotein: tyrosine kinase inhibitors called into question | CRCM","og_description":"Published in Cellular and Molecular Gastroenterology and Hepatology, the De Sepulveda team's study demonstrates that the MAN2A1-FER oncoprotein, present in several cancers, lacks kinase activity, calling into question the efficacy of tyrosine kinase inhibitors as a therapeutic strategy.","og_url":"https:\/\/crcm-marseille.fr\/en\/scientific-publication\/de-sepulveda-team-reveals-kinase-inactivity-of-man2a1-fer-oncoprotein-tyrosine-kinase-inhibitors-called-into-question\/","og_site_name":"CRCM","article_published_time":"2025-01-28T13:41:13+00:00","article_modified_time":"2025-04-23T14:30:40+00:00","og_image":[{"width":760,"height":453,"url":"https:\/\/crcm-marseille.fr\/wp-content\/uploads\/2025\/01\/Sepulveda-News-2.jpg","type":"image\/jpeg"}],"author":"L\u00e9a Girard","twitter_card":"summary_large_image","twitter_misc":{"Written by":"L\u00e9a Girard","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/crcm-marseille.fr\/en\/scientific-publication\/de-sepulveda-team-reveals-kinase-inactivity-of-man2a1-fer-oncoprotein-tyrosine-kinase-inhibitors-called-into-question\/#article","isPartOf":{"@id":"https:\/\/crcm-marseille.fr\/en\/scientific-publication\/de-sepulveda-team-reveals-kinase-inactivity-of-man2a1-fer-oncoprotein-tyrosine-kinase-inhibitors-called-into-question\/"},"author":{"name":"L\u00e9a Girard","@id":"https:\/\/crcm-marseille.fr\/en\/#\/schema\/person\/62f07336c4eae6ba5829ec04ad81b1e3"},"headline":"De Sepulveda team reveals kinase inactivity of MAN2A1-FER oncoprotein: tyrosine kinase inhibitors called into question","datePublished":"2025-01-28T13:41:13+00:00","dateModified":"2025-04-23T14:30:40+00:00","mainEntityOfPage":{"@id":"https:\/\/crcm-marseille.fr\/en\/scientific-publication\/de-sepulveda-team-reveals-kinase-inactivity-of-man2a1-fer-oncoprotein-tyrosine-kinase-inhibitors-called-into-question\/"},"wordCount":153,"commentCount":0,"publisher":{"@id":"https:\/\/crcm-marseille.fr\/en\/#organization"},"image":{"@id":"https:\/\/crcm-marseille.fr\/en\/scientific-publication\/de-sepulveda-team-reveals-kinase-inactivity-of-man2a1-fer-oncoprotein-tyrosine-kinase-inhibitors-called-into-question\/#primaryimage"},"thumbnailUrl":"https:\/\/crcm-marseille.fr\/wp-content\/uploads\/2025\/01\/Sepulveda-News-2.jpg","articleSection":["OHIO Department","Scientific publication","Sepulveda team"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/crcm-marseille.fr\/en\/scientific-publication\/de-sepulveda-team-reveals-kinase-inactivity-of-man2a1-fer-oncoprotein-tyrosine-kinase-inhibitors-called-into-question\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/crcm-marseille.fr\/en\/scientific-publication\/de-sepulveda-team-reveals-kinase-inactivity-of-man2a1-fer-oncoprotein-tyrosine-kinase-inhibitors-called-into-question\/","url":"https:\/\/crcm-marseille.fr\/en\/scientific-publication\/de-sepulveda-team-reveals-kinase-inactivity-of-man2a1-fer-oncoprotein-tyrosine-kinase-inhibitors-called-into-question\/","name":"De Sepulveda team reveals kinase inactivity of MAN2A1-FER oncoprotein: tyrosine kinase inhibitors called into question | CRCM","isPartOf":{"@id":"https:\/\/crcm-marseille.fr\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/crcm-marseille.fr\/en\/scientific-publication\/de-sepulveda-team-reveals-kinase-inactivity-of-man2a1-fer-oncoprotein-tyrosine-kinase-inhibitors-called-into-question\/#primaryimage"},"image":{"@id":"https:\/\/crcm-marseille.fr\/en\/scientific-publication\/de-sepulveda-team-reveals-kinase-inactivity-of-man2a1-fer-oncoprotein-tyrosine-kinase-inhibitors-called-into-question\/#primaryimage"},"thumbnailUrl":"https:\/\/crcm-marseille.fr\/wp-content\/uploads\/2025\/01\/Sepulveda-News-2.jpg","datePublished":"2025-01-28T13:41:13+00:00","dateModified":"2025-04-23T14:30:40+00:00","breadcrumb":{"@id":"https:\/\/crcm-marseille.fr\/en\/scientific-publication\/de-sepulveda-team-reveals-kinase-inactivity-of-man2a1-fer-oncoprotein-tyrosine-kinase-inhibitors-called-into-question\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/crcm-marseille.fr\/en\/scientific-publication\/de-sepulveda-team-reveals-kinase-inactivity-of-man2a1-fer-oncoprotein-tyrosine-kinase-inhibitors-called-into-question\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/crcm-marseille.fr\/en\/scientific-publication\/de-sepulveda-team-reveals-kinase-inactivity-of-man2a1-fer-oncoprotein-tyrosine-kinase-inhibitors-called-into-question\/#primaryimage","url":"https:\/\/crcm-marseille.fr\/wp-content\/uploads\/2025\/01\/Sepulveda-News-2.jpg","contentUrl":"https:\/\/crcm-marseille.fr\/wp-content\/uploads\/2025\/01\/Sepulveda-News-2.jpg","width":760,"height":453},{"@type":"BreadcrumbList","@id":"https:\/\/crcm-marseille.fr\/en\/scientific-publication\/de-sepulveda-team-reveals-kinase-inactivity-of-man2a1-fer-oncoprotein-tyrosine-kinase-inhibitors-called-into-question\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/crcm-marseille.fr\/en\/"},{"@type":"ListItem","position":2,"name":"De Sepulveda team reveals kinase inactivity of MAN2A1-FER oncoprotein: tyrosine kinase inhibitors called into question"}]},{"@type":"WebSite","@id":"https:\/\/crcm-marseille.fr\/en\/#website","url":"https:\/\/crcm-marseille.fr\/en\/","name":"CRCM","description":"Marseille Cancer Research Center","publisher":{"@id":"https:\/\/crcm-marseille.fr\/en\/#organization"},"alternateName":"Centre de recherche en canc\u00e9rologie de Marseille","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/crcm-marseille.fr\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/crcm-marseille.fr\/en\/#organization","name":"CRCM","alternateName":"Centre de Recherche en Canc\u00e9rologie de Marseille","url":"https:\/\/crcm-marseille.fr\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/crcm-marseille.fr\/en\/#\/schema\/logo\/image\/","url":"https:\/\/crcm-marseille.fr\/wp-content\/uploads\/2024\/10\/logo-crcm.png","contentUrl":"https:\/\/crcm-marseille.fr\/wp-content\/uploads\/2024\/10\/logo-crcm.png","width":11811,"height":7171,"caption":"CRCM"},"image":{"@id":"https:\/\/crcm-marseille.fr\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.youtube.com\/@CRCM-marseille","https:\/\/www.linkedin.com\/company\/crcm-marseille\/","https:\/\/bsky.app\/profile\/crcm.bsky.social"]},{"@type":"Person","@id":"https:\/\/crcm-marseille.fr\/en\/#\/schema\/person\/62f07336c4eae6ba5829ec04ad81b1e3","name":"L\u00e9a Girard","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/crcm-marseille.fr\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/88ca43e6c11426af328e079c9e0e2998cafa03182fedc1404c00f26df9087825?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/88ca43e6c11426af328e079c9e0e2998cafa03182fedc1404c00f26df9087825?s=96&d=mm&r=g","caption":"L\u00e9a Girard"},"url":"https:\/\/crcm-marseille.fr\/en\/author\/lea-girard\/"}]}},"_links":{"self":[{"href":"https:\/\/crcm-marseille.fr\/en\/wp-json\/wp\/v2\/posts\/5727","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/crcm-marseille.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/crcm-marseille.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/crcm-marseille.fr\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/crcm-marseille.fr\/en\/wp-json\/wp\/v2\/comments?post=5727"}],"version-history":[{"count":0,"href":"https:\/\/crcm-marseille.fr\/en\/wp-json\/wp\/v2\/posts\/5727\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/crcm-marseille.fr\/en\/wp-json\/wp\/v2\/media\/5471"}],"wp:attachment":[{"href":"https:\/\/crcm-marseille.fr\/en\/wp-json\/wp\/v2\/media?parent=5727"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/crcm-marseille.fr\/en\/wp-json\/wp\/v2\/categories?post=5727"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/crcm-marseille.fr\/en\/wp-json\/wp\/v2\/tags?post=5727"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}